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The End of Single-Molecule Envy
Molecular interactions can be detected using single
uengineered ion channels as stochastic sensors. This
tapproach is used to examine events between a kinase
[and an inhibitor peptide tethered to an engineered
t
channel [1] showing agreement with macroscopic
bbiochemical data, as well as a tantalizing surprise. t
h
Most of our knowledge of the behavior of biological i
molecules is derived from macroscopic studies which t
measure the activity of thousands or millions of mole- s
cules. The activity of single molecules (or single macro- d
molecular complexes) can be measured—albeit for t
relatively few classes of biological molecules. Micro- c
dscopic studies reveal that events that occur at the sin-le-molecule level cannot be described as determinis-
ic, but are stochastic. That is, the behavior of single
olecules is probabilistic. Single behavior of ion chan-
els was shown first three and a half decades ago
sing sensitive amplifiers to measure the activity of cer-
ain antibiotics that act as ion channels in lipid bilayers
2]. The development of patch clamp not long af-
erwards fueled explosive interest in single-molecule
ehavior, augmented further by the cloning and func-
ional characterization of ion channels. These were
eady days indeed, prompting one leading researcher
n the field to quip that the enterprise was so heroic
hat it could be portrayed in the style of a Soviet-era
ocial realist poster depicting an intrepid graduate stu-
ent at work proclaiming in bold script “one investiga-
or, one rig, one molecule!” Detailed kinetic behavior
an be mined from the richness of single-molecule
ata. For example, complex models of ion channel
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9functional substates have been developed in part from
single-channel recordings.
So are investigators of other important biological
molecules, including protein kinases, left to languish in
single-molecule envy? Hagan Bayley’s laboratory has
established a highly innovative approach incorporating
elements of chemistry and biology that permits the
measurement of single (and bimolecular) behavior of a
growing and varied class of molecules [3]. This is
achieved by chemically coupling small molecules of in-
terest (including ligands for much larger molecules) to
genetically modified staphylococcal α-hemolysin ion
channel pores that act as sensors. This scheme for the
article herein is depicted in Figure 1. A high-resolution
structure of the α-hemolysin channel was solved a
number of years ago by a collaborative effort that in-
cluded Eric Gouaux and Bayley [4]. The heptameric
α-hemolysin channel has a distinct cis side mushroom-
shaped cap with a β barrel stem that crosses the lipid
bilayer with an average pore diameter of 20 Å through
the stem. Following synthesis and preparative biochemi-
cal fractionation of subunits, α-hemolysin channels are
incorporated into membranes with known stoichiometry
and measured for single-channel electrophysiological
recording using a standard bilayer apparatus. Stochas-
tic sensing by modified α-hemolysin channels has been
used by Bayley’s group to measure a variety of analytes
including proteins. Single binding events between large
receptor molecules including proteins and ligands teth-
ered to the modified α-hemolysis channels are reported
as changes in the amplitude and ionic selectivity in
single-channel recordings [5]. Within this issue, Xie,
Bayley, and colleagues describe the implementation of
their approach to measure single-molecule interactions
between the catalytic subunit of cAMP-dependent pro-
tein kinase (PKAc) and a protein kinase inhibitor pep-Figure 1. Molecular Model of the α-Hemoly-
sin Channel with Tethered PKIP Bound to the
Catalytic Subunit of cAMP-Dependent Pro-
tein Kinase
Single-channel conductance is altered when
binding occurs; thus, the engineered chan-
nel acts as a reporter for kinase/inhibitor
binding events [1].tide (PKIP) that is tethered to the end of the stem trans
side of the channel pore with a flexible chain of tetra
ethylene glycol [1].
The stochastic sensing experiments with the modi-
fied α-hemolysin channel and the catalytic subunit of
PKAc yielded results that validate the system—and
some intriguing surprises as well. Current-voltage
curves determined from single-channel current record-
ings of wild-type and PKIP-tethered α-hemolysin chan-
nels are similar, indicating that the PKIP peptide does
not appear to interact with the transmembrane barrel
pore by itself. Microscopic kinetic and binding con-
stants of PKAc interaction with PKIP determined by
stochastic sensing at a given intermediate membrane
potential are similar to those values determined by
macroscopic measurements made in bulk solution.
These are exciting results, as protein kinases are criti-
cal regulators of many physiological processes and are
important targets for potential drug therapies. High-
throughput screening of protein kinase modulators
could yield rapidly acquired and highly detailed data
sets if stochastic sensing approaches could be scaled-
up and made to be more robust. PKAc is relatively well
understood in terms of high-resolution structure, mo-
lecular mechanism, and pharmacology. The general ap-
proach of single-channel stochastic sensing is broadly
applicable to many proteins—including those that are
much less understood.
Most unexpectedly, Xie and colleagues found that
microscopic kinetic and binding constants derived from
tethered PKIP and PKAc are influenced profoundly by
applied membrane potential. In contrast to the binding
events between the tethered PKIP and PKAc that are
observed at the applied potential of −80 mV, curiously,
no binding events are observed at positive potentials.
This raises questions about the voltage dependence of
Chemistry & Biology
10binding and the behavior of proteins at the membrane c
tsurface. Many signal transduction events occur at the
cell membrane. For a few well-characterized examples c
msuch as Ras and Src, we know that a combination of
electrostatic interactions and lipid modifications influ- s
mence signaling at the membrane [6]. However, there is
a growing body of evidence that suggests that the ac- a
ltivity of other membrane-associated signaling proteins,
including protein kinases, are influenced by voltage t
gchanges at the membrane [7, 8]. At first glance, the
voltage-dependent differences in stochastic sensing of o
dthe interactions between tethered PKIP and PKAc ap-
pear to be an unexplained quirky feature of the mea- s
surement. Perhaps these unexpected results may lead
to powerful new studies to examine the voltage-depen- T
dent behavior of proteins kinases and other important D
signaling molecules at the membrane interface. N
The work described above signifies the latest pro- N
gress in ion channel engineering, a new field which has
two major branches. One is devoted to in vivo/thera-
Speutic applications and the other to sensor technology.
Recently, engineered channels have been applied to in
vivo studies for manipulating electrical excitability in
specific neural circuits in transgenic animals [9, 10].
Other work examining expressed engineered channels
in cultured neurons in vitro shows that rapid temporal
control over the activity of engineered ion channels can
be achieved by small chemical ligands or light [11, 12].
These results point to future potential therapeutic appli-
cations for engineered ion channels. The use of engi-
neered ion channels as sensors has been in existence
for a few years longer. The earliest examples of ion
channels as chemical sensors made use of naturally
occurring channels. “Patch-cramming,” developed by
Richard Kramer, was one notable early example of nat-
urally occurring ion channels used as chemical sensors
1[13]. The work of Bayley’s group builds on this through
the development of engineered channels as specific
1sensors. To date, virtually all engineered ion channels
have been constructed using naturally occurring ion 1
channels as scaffolds. Selection-based membrane pro-
1tein evolution and de novo design of engineered ionhannels are areas that will probably receive substan-
ial attention in the near future. Specifically regarding
hemical sensors, there are several challenges that
ust be solved in order to make channel-based sen-
ors useful as an industrial technology [3]. First, they
ust be made more physically robust so that they are
ble to withstand the passage of large volumes of ana-
ytes over time. Second, channel-based sensors need
o be scaled-up to true multiplex systems to allow for
reater throughput. If these technical hurdles can be
vercome, then engineered ion channels will likely be
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